We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cabozantinib in Men With Castration-Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01703065
Recruitment Status : Terminated (Closed 2017 for low accrual. Last data for primary outcome on 02Feb2015.)
First Posted : October 10, 2012
Last Update Posted : December 5, 2017
Sponsor:
Collaborators:
Prostate Cancer Foundation
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Celestia Higano, University of Washington

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : February 2, 2015
  Study Completion Date : September 18, 2015
  Certification or Request for Extension to Delay Results Submission: October 16, 2017